United States · FDA National Drug Code directory
Papaverine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0517-4002_402161da-fe45-4b0f-a5ca-a230593cc434
- Product NDC
- 0517-4002
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Papaverine Hydrochloride
- Labeler
- American Regent, Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 19950901
- Source listing expiry
- 20271231
Source-listed ingredients
- PAPAVERINE HYDROCHLORIDE — 30 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (0517-4002-25) / 2 mL in 1 VIAL (0517-4002-01) · 0517-4002-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →